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Secretory and Accessory Cell Functions
of the Alveolar Macrophage
by Kiara Miller,' Barry N. Hudspith,l and Clive
Meredith'
1W haveattemptedtoaddres therequirements necessaryforalveolarmacrophageaccessorycell function. 1W have
alsoe ined thein vtn andusWivofactorsthatmustbetakenintoaccountwheninterpreting rsultsfromexperimen-
talstudies. Differencesinphenotypic expressionbyratalveolarpleuralandperitonealmacrophagesarenoted, aswel
as the diffenng expression of major histocompatibility complex (MHC) class H molecules. Furthermore, alveolar
macrophas harvestedfromratlung,donoteqps thehrkin(IL-1cytokines,andlipopolyacharlde (LPS)treat-
mentofqulesentcels(after24-hrin vbculu)induceslw klew of p noflL-laandELA16. Short-terminhalation




tivationofdendriticceUsduringtheafferentlimboftheimnune response, andthey wouldrespondtoproductsofsen-
sitizedT-celssuchasinterferon-y andIL-4 tointeractwithT-helperceUlsinanantigen-spedfic MHC-restricted man-
nerduring theefferent limboftheresponse.
Introduction
In 1972, cells classified as mononuclear phagocyte were
grouped together on the basis ofhaving a common origin as
demonstrated by kinetic studies and similar morphology,
cytochemistry, andfunction(1). Theconcepthadtheadvantage
ofsimplicityandwould, it wasthought, helpclarifytheroleof
mononuclear phagocytes in physiological and certain patho-
logical conditions.
Fifteen years later, however, there is ample evidence that
despitetheirprobableoriginfrom a commonbonemarrow pro-
genitorpopulation(2), macrophagesfromdifferentsitesdisplay
considerableheterogeneity. This diversity is expressedby dif-
ferences in phenotypic expression, secretory products, im-
munoregulation, and presentation ofantigen. They also show
differences in energy source. Some of these differences are
discussed inthecontextofthe secretoryand accessory cellfunc-
tions ofthe alveolar macrophage.
Phenotypic Subsets of Macrophages
Numerous reports exist ofmonoclonal antibodies that label
macrophage/monocyte subpopulations in mouseand man, and
in someinstancesthesephenotypically definedsubsetshavebeen
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shown to mediate specific function. For example, the murine







one in Oxford (4), the other in Amsterdam (5), have clearly
demonstrated differences between alveolar macrophages and
macrophagesfromdifferentsites,aswellasheterogeneityamong
the alveolar macrophages. Our own findings are in agreement
with the published reports (4,5) in observing that alveolar
macrophagesaredividedintosubsets;additionally, wefinddif-
ferencesinexpressionbetweenalveolar,pleural,andperitoneal
macrophages (Table 1). BothMRCOX-41 andMRCOX-42an-
tibodiesrecognizecell-surfaceproteinsthataresynthesizedby
macrophages, although they also label granulocytes. MRC
OX-42recognizesanantigenassociatedwithcomplementfunc-
tion(theiC3b-receptor). EDI andED2recognizemononuclear
phagocytes exclusively; EDI recognizesacytoplasmicantigen,
whereas ED2binds to membrane antigen. We foundthatcells
recoveredbybronchoalveolarlavage(BAL)fromPVGratswere
ED1 positiveandED2negative; 90% wereOX-41 positive and
20-30% were positive for OX-42. By contrast the majority of
pleuralmacrophagesboundallfourantibodies, whereasresident
peritonealmacrophagesboundOX-41,OX-42,andEDI,butonly
50% recognizedtheED2antibody (Table2). Thus, peritoneal
macrophagesdifferfrompleuralcellsintheirphenotypicappear-MILLERETAL.
Table 1. Distribution andstaining patternofrat macrophages
byEDI andED2.
Macrophage type EDI (%) ED2 (%)
Peritoneal macrophages (resident) + + +(90) + + (45)
Pleural macrophages + + +(80) + + +(90)
Alveolar macrophages + + +(80) -
Lung "tissue" macrophages + (10) + + +(80)





Preculture time for 3 hr IL-la IL-10 Fibronectin
0 hr
Control No - - +
Test No - - +
24 hr
Control Medium only - - +
Test Medium only - - +
24 hr
Control LPS -/+ -/+ +
Test LPS + +++ + +
Abbreviations: IL-1, interleukin-l; LPS, lipopolysaccharide.
aExposure to 10mg/m3, 6hr/day for5 days.
anceandbothdifferfromalveolarmacrophages. Ofparticular
interest here is the observation that when macrophages were
isolatedfromlungtissue, 80% werepositiveforED2, butonly
10% labeledwithEDI. Althoughitistemptingtospeculatethat
ED2 is adifferentiation antigen, onestudy usingboth resident
and elicited peritoneal macrophages showed a decrease in
ED2-positivecellsfrom53to 13% (6). However, itmaystillbe
that monocytes oralveolar macrophages enter thelung paren-
chyma and differentiate into ED2-positive pulmonary tissue
macrophages under the influence ofvarious stimuli. It is also
possible that alveolar macrophages under the stimulus of
cytokinesproducedbysensitizedT-lymphocyteswillmatureinto
ED2-positive cells. Ourown experiments where rats have in-
haled mineral fibers demonstrate that phagocytosis per se in-
ducesnoalterationwithrespecttothesemembraneantigens. All
one can say at present is that all free-lying macrophages are
positive for the intracellular antigen EDI and thatED2 recog-
nizesamembraneantigenpresentonmosttissuemacrophages.
Resident pleural macrophages, anatomically located in close
proximity toalveolarmacrophages, appeartosharethepheno-
typic characteristic ofa subsetofperitoneal macrophages.
Anotherimportantdififrencebetweenratpleuralandalveolar
macrophagesistheexpressionofmajorhistocompatibility com-
plex (MHC) class II (Ia) molecules on the surface membrane,
saidtocorrelatewiththeabilitytopresentantigenandstimulate





increased by as much as 6-fold during and immediately after
fiber exposure, and this was paralleled by similarincreases in
OX-42-positivecells. However, althoughthemajorityoflavaged




sion did not appear to relate to activation by "nonantigenic"
fibersandmightperhapsbe inducedby inflammatory stimuli.
In the normal state, few neutrophils were recovered by bron-
choalveolarlavage, butinhalationoffibersresultedinanincrease
from2to 14.5% intestrats3daysafterexposure. Itmaybethat
proteasesorothermediatorsreleasedbytheneutrophilsactivated






a subject of some considerable controversy in the published
literature. One currently accepted postulate is that, at least in
man, alveolarmacrophagesarecapableofsupportingantigen-







unlike peritoneal and pleural macrophages, is independent of
PGEproduction(8)(Fig.2). Intheseexperimentsmacrophages
were prereated for 20 hr with either interferon (IFN)-,o or





study to characterize the factors contained in the conditioned
media; however, the suggestion is that lymphocyte products
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FIGURE 2. Effect oflymphokine (LK) and interferon-f3 (IFN-fl) treatment on
prostaglandin release from different macrophage populations. After Sestini
etal. (8).
allow full expression ofthe immune response. No such effect,
however, wasfound onthe suppressoractivity ofperitonealcells.
This is very puzzling because there is evidence from other
studies that rIFN can reproduce the effects oflymphokine-rich
culture medium from antigen- ormitogen-activated T-cells on
macrophages. IFN is a strong signal for regulation ofclass II
MHC on antigen-presenting cells.
Returning to human alveolar macrophage for the moment,
studies havealso reportedthat even small numbers ofcells can
suppress lymphocyte proliferation by peripheral blood mono-
nuclearcellswhenoptimal concentrations ofmitogen orantigen
are used (9). These authors suggest that alveolar cells produce
suppression via interactions with suppressor T-lymphocytes.








Itisoftenstatedthatthree requirements areessential for acell
tofunctionoptimally inantigenpresentation: thecapacitytopro-
cessantigen, thecapacity to synthesizeandreleasesecondary ac-
cessory factors such as interleukin 1 (IL-1), and thecapacity to
express class II MHC glycoproteins on its plasmamembrane.




junction with anMHCantigen, generally as apeptidefragment.
The next question therefore must be whether monocytes and
macrophages synthesize IL-1, a co-stimulator signal said to be
necessary forcelldivisionandproducedby avarietyofcell types
including endothelial cells, B-cells, and keratinocytes.
There can be no doubt that in vitro culture conditions have
greatly affected our interpretation ofmacrophage functions in








tein represents the predominant 11-1 secreted by mononuclear
phagocyte); by 18 hr the cells were quiescent with regard to
transcriptionofthecytokinesexamined, namely, IL-1,IL-6, and
tumor necrosis factor (TNF)-a (10). There is little reason to
believethatsecretedcytokinesarenotpresentasresponsestothe
phagocytic stimulithatwouldoccuras aconsequenceof 1 or2
hr adherence purification procedures. Such responses could
sometimes be interpreted as part ofthe immunoregulatory or
secretory functions of macrophages. Macrophages harvested
from lymphoidorgans orfromtheperitoneal cavity do not ex-
press IL-la or IL-1I8 mRNA or protein (12), nor do freshly
isolatedmonocytes. However, afterstimulationwithlipopolysac-
charide(LPS) underappropriatein vitroconditions, significant
levelsofthese mRNAs canbedetected.
Macrophagesfromdifferentsites,however, showconsiderable
differences intheexpressionofcytokines. Forexample, studies
on fresh human alveolar macrophages and blood monocyte
demonstratedifferences in releaseofcytokines (13). Alveolar
macrophages releaselowamountsofIL-1,8in responseto LPS
andhighamountsorTNF-ax, whereasbloodmonocytesrelease
abundantamounts ofIL-1,8butlow amounts ofTNF.
Anothercytokine, fibronectin, which isimportantinnormal
tissueturnover, woundrepair,andinflanunatoryprocesses,isnot
expressedinbloodmonocytesbutisexpressedbymaturemono-
nuclear phagocytes, including alveolar and peritoneal macro-
phages (14). However, in some circumstances such as when
alveolarmacrophagesareactivatedbysurfacestimuli,fibronectin





cytokinegenesjustasthereappears tobedifferences inthe ac-
cessoryactivityofalveolarmacrophagesfromguineapig, rab-
bit, orrat. Inagreementwithothers, wefindthatalveolarmacro-
phages, harvestedfromratlung,donotexpresstheIL-1 cytokine
genes, and LPS treatment induces low levels ofexpression of
ILI-axorIL-,8. Short-term(5day)inhalationexposuretorefrac-
tory ceramicfibersdid notinitselfcause anincreaseinIL-1 or
fibronectingeneexpression. Afterthesecellsbecamequiescent,
however, andthenwerestimulatedwithLPSfor3hrIL-1 expres-














provided by interleukin-l. However, it should be remembered
thatIL-1 mediates awidevariety ofbiological responses to in-
juryandinfectionincludingtheproductionoftheprostaglandin
E series, pyrogenicity, and tissue destruction. IL-1 is also se-
creted in response to a wide range of antigen-independent




(which include the tissue dendritic cell, e.g., the Langerhans
cells), andthey do notproduce interleukin-1 (16,17).
The dendritic cell lacks most conventional surface markers
associatedwiththemonocyte/macrophagelineage, anditis not
clearwhethertheprecursorisadiscretecirculatingcellorpart
of the conventional mononuclear phagocyte population (18).
Dendriticcellspossesslongmobilecytoplasmicprocesses, are
notphagocytic, have fewlysosomes, and stainweakly for non-
specificesteraseandATPase. Theydonotproliferateinculture,
do notexpress Fc receptors, butexpressionofclass IIantigens
is very strong, andthedendritic cellplays an importantrole in
helper T-cell activation. Dendritic cells from all species and
tissuesthathavebeenexaminedtodatehaveproventobepotent
stimulatorsoftheautologousmixed-leukocytereaction(MLR)
and ofin vitro mitogen- and antigen-induced lymphocyte pro-
liferation. Investigators havealso founddendritic cellsto induce
both the releaseofIL-2andtheresponsivenessofT-cellstoIL-2
(19).
Recently, several studies on both human and rat lung have
demonstrated the presence ofsignificant numbersofdendritic




during localimmune responses inthelung suggestthatthe ac-
cessorycellinthelungparenchymaisthedendriticcell. Thisap-
pears to leavethe roleofalveolarmacrophages moreconfused
thanever. However, whenaccessory functionsinvolvedinboth






only formclusters withactivatedT-helpercells inthepresence
ofantigen(24) andb) importantdevelopmental eventsthatmay
occurduring the maturation ofdendritic cells.
Little isknownabouttheeventsoccurringduringpulmonary
dendriticcellmaturation, soit isstillunclearwhethertheymight
proliferatelocally or maturewithinthelungtissue. Far moreis
knownofthematurationandpropertiesoftheLangerhanscell,
as it is relatively easy to isolate from skin sources. Two recent
reports on murine Langerhan cells cultured in vitrohave iden-
tified a major role for granulocyte/macrophage colony-stimu-
latingfactor(GM-CSF) intheaccessoryimmunological matura-
tionandfunctionofLangerhanscells(LC)(25,26). Bothgroups
made useofconditioned mediafromkeratinocytecultures and
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as in stimulated macrophages. The keratinocyte-conditioned











mobilize dendritic cells from a weakly active, nonlymphoid
tissueandturnthemintopotentimmunostimulatorycells.These
ofcoursecanbereleasedintheabsenceofsensitizedT-cells. A
recent publication (27) has shown that rat peritoneal
macrophages can be activated to produce GM-CSF and that
macrophage-conditionedmediumcontainingIL-1andGM-CSF
enhances theaccessory activity ofdendritic cells.
Althoughthestudiesdescribedabovedonotspecificallyrelate
to the lung, the important point is that GM-CSF and IL-1 are
cytokines produced by non-T-cells such as macrophages and
keratinocytes. Becausealveolarmacrophagesareamongthefirst
cellstoencounterantigensdepositedinanonlymphoidenviron-
ment, they maybecriticallyimportantinmodulatingthe func-





productionandreleaseofIL-1, TNF, andprostaglandins. There
isanurgentneedtostudythecapacityofalveolarmacrophages
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to express GM-CSF under different conditions of exposure.
These of course can be released in the absence of sensitized
T-cells.
Let us therefore test the hypothesis that the alveolar macro-
phageplaystwoimportantimmunoregulatoryroles. Duringthe
afferent limb of the immune response they release cytokines










and Safety Executive to whomourthanks aredue.
REFERENCES
1. vanFurth, R.,Cohn, Z., Hirsch, J. G., Spector, W. G., andLangervoort, H.
L. Themononuclearphagocytesystem: anewclassificationofmacrcphages,
monocytes andtheirprecursorcells. Bull. WHO46 (1972).
2. vanFurth, R. Current view on the mononuclear phagocyte system. Im-
munobiology 161: 178-187 (1982).
3. Knowles, D. M., Tolidjien, B., Marboe. C., D'Agati, V.,Grimes, M., and
Chess, L. Monoclonalanti-human monocyteantibodiesOKMI andOKM5
possessdistinctivetissuedistributionincludingdifferential reactivity with
vascularendothelium. J. Immunol. 132: 2170-2173 (1984).
4. Robinson, A. P.,White, T. M.,andMason, D. W.Macrophageheterogeneity
inthe ratasdelinatedbytwomonoclonalantibodiesMRCOX-41 andMRC
OX-42. Immunology 57:239-247 (1986).
5. Dijkstra, C. D., Dopp, E. A.,Jopling, P., andKroal, C. Theheterogeneity
ofmononuclearphagocytes inlymphoidorgans: distinctmacrophagesub-
populationsintheratrecognizedbymonoclonal antibodies EDI, ED2and
ED3. Immunology 54: 589-599 (1985).
6. Damoiseaux,J. G. M. C., Dopp, E. A.,Neafies,J.J.,Beelen,R. H.J.,and
Dijkstra, C. D. Heterogeneity of macrophages in the rat evidenced by
variability indeterminants. J. Leukocyte Biol. 46: 556-564 (1989).
7. Rich, E. A.,Tweardy, D.J., Fijiwara, H.,andEllner,J.J. Spectrumofim-
munoregulatory functionsandpropertiesofhumanalveolarmacrophages.
Am. Rev. Respir. Dis. 1236: 258-265 (1987).
8. Sestini, P., Tagliabue, A.,andBomschi, D. Modulationofmacrophagesup-
pressiveactivityandprostaglandinreleasebylymphokinesandinterferon.
Clin. Exp. Immunol. 58: 573-580(1984).
9. Ettensohn, D. B.,Lalor, P. A.,andRobert, N.J.Humanalveolarmacophage
regulation oflymphocyte proliferation. 133: 1091-1096 (1986).
10. Meredith, C., Scott, M. P., Pekelharing, H., and Killer, K. The effectof
Biostim (RU 41740) on the expression of cytokine in RNAs in murine
peritoneal macrophages in Wtro. Toxicol. Lett. 53: 327-337 (1990).
11. Danis, V. A., Kulesz, A. J., Nelson, D. S., and Brooks, P. M. Cytokine
regulation ofhumanmonocyteinterleukin-l (IL-1)productionin vitro. Clin.
Exp. Immunol. 80: 435-443 (1990).
12. Fuhlbrigge, R. C.,Chaplin, D. D.,Kiely,J.-M., andUrnanue, E. R. Regula-
tionofinterleukin-I geneexpressionbyadherenceandlipopolysaccharide.
J. Immunol. 138: 3799-3802 (1987).
13. Wewers, M., and Herzyk, D. J. Alvolar macrophages differ from blood
monocytes inhuman IL-,8 release. J. Immunol. 143: 1635-1641 (1989).
14. Adachi, R., Yamuchi, K., Bernaudin, J. F., Fouret, P., Ferrans, V. J., and
Crystal, R. G. Evaluationoffibronectingeneexpressionbyinsituhybridiza-
tion. Am. J. Pathol. 133: 193-203 (1988).
15. Miller, K.,andHudspith,B. N. Investigationintotheeffectsofinhaledman-
mademineralfibresonalveolarandpleumlcellpopulations. Hum. Exp. Tox-
icol. 10: 83-84 (1991).
16. Steinman, R. M., Inaba, K., Schuber, G., andWitmer, M. Stimulation of
the immuneresponse: contributions ofdendritic cells. In: Mechanisms of
HostResistance (R. M. Steinman andR. J. North, Eds.), TheRockefeller
University Press, NewYork, 1986, pp. 71-97.
17. Steinman, R. M. Cytokines amplify the function ofaccessory cells. Im-
munol. Lett. 17: 197-202 (1988).
18. King, R. D., and Katz, D. R. Mechanisms ofdendritic cell function. Im-
munol. Today 11: 206-211 (1990).
19. Austyn, J. M., Steinman, R. M., Weinstein, D. E., Granalli-Piperno, A.,
andPalladino, M. A. Dendriticcellsinitiateatwo-stagemechanism forT-
lymphocyte proliferation. J. Exp. Med. 157: 1101-1115(1983).
20. Nicod, L. P.,Lipscomb, M. F.,Weissler,J. C., Lyons,C. R.,Alberton,J.,
andToews, G. B. Mononuclearcellsinhumanlungparenchyma: character-
izationofapotentaccessorcellnotobtainedbybronchoalveolarlavage. Am.
Rev. Respir. Dis. 136: 818-823 (1987).
21. Holt. P. G.,andSchon-Herrad, M. A. LocalisationofTcells, macrophages
and dendritic cells in respiratory tract tissue. Immunology 62: 349-356
(1987).
22. Rochester,C L.,Goddell, E.M.,Stoltenborg,J.K.,andBowers,W E. Den-
driticcells from ratlungarepotentaccessorycells. Am. Rev. Respir. Dis.
138: 121-128 (1988).
23. Holt, P. G., Schon-Hegrad, M. A.,Oliver,J., Holt, B. J.,andMcMenamin,
P. G. Acontinuousnetworkofdendriticantigen-presentingcells withinthe
respirtoryepitheium. Font.Arch.AllergyAppl.Immunol.91:155-159(1990).
24. Inaba, K., andSteinman, R. M. Restingandsensitised Tlymphocytes ex-
hibitdistinctstimulatory (antigenpresentingcell)requirements forgrowth
andlymphokine release. J. Exp. Med. 165: 1403-1417 (1987).
25. Witmer-Pack, M. D., Olivier, W, Valinsky,J., Schuler, G., andSteinman,
R. M.Granulocytelmacrophagecolony-stmulating factorisessentialforthe
viability andfunctionofculturedmurineepidermal Langeha cells.J. Exp.
Med. 166: 1484-1498 (1987).
26. Heufler, C., Koch, F., and Schuler, G. Granulocyte/macrophage colony-
stimulating ctorandinterleukin 1 mediatethemaurationofmurineepider-
malLangerhanscells intopotentimmunostimulatorydendriticcells. J. Exp.
Med. 167:700-705 (1988).
27. Bowers, W E.,Ruhoff, M. S.,andGodell, E. M. Conditionedmedium from
activatedratmacrophages andtherecombinantfactors, IL-1 andGM-CSF,
enhance the accessory activity ofdendrictic cells. Immunobiology 180:
362-384(1990).